Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Know More: Is India's Economic Recovery Sustainable?

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 679.05 -4.54% 679.05 -4.73%
 More Info 
AJANTA PHARMA 1,576.00 -0.02% 1,585.95 0.40%
 More Info 
ALEMBIC PHARMA 960.00 0.18% 956.90 -0.36%
 More Info 
BIOCON 406.30 0.94% 407.00 1.11%
 More Info 
CADILA HEALTHCARE 420.45 0.51% 420.80 0.47%
 More Info 
CIPLA 754.50 1.27% 752.70 0.74%
 More Info 
DIVIS LABORATORIES 3,100.95 1.97% 3,086.35 1.45%
 More Info 
DR. REDDYS LAB 4,993.00 0.26% 4,998.05 0.40%
 More Info 
GLENMARK PHARMA 480.50 0.59% 480.95 0.66%
 More Info 
INDOCO REMEDIES 252.45 -1.04% 252.25 -0.20%
 More Info 
IPCA LABS 2,183.85 2.61% 2,189.00 3.07%
 More Info 
J.B.CHEMICALS 1,015.00 0.77% 1,007.00 -0.04%
 More Info 
LUPIN 968.60 0.56% 968.40 0.57%
 More Info 
NATCO PHARMA 907.30 -1.37% 906.20 -0.35%
 More Info 
NIFTY 50 Not Listed 11,789.00 0.18%
 More Info 
ORCHID PHARMA 5.25 -4.89% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 181.95 1.56% 177.55 -0.95%
 More Info 
PIRAMAL ENTERPRISES 1,294.25 -0.50% 1,292.25 -0.65%
 More Info 
S&P BSE HEALTHCARE 19,452.80 0.43% Not Listed
 More Info 
S&P BSE SENSEX 40,157.06 0.03% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 748.30 0.02% 747.20 -0.18%
 More Info 
SUN PHARMA 474.40 -0.01% 475.05 0.12%
 More Info 
TORRENT PHARMA 2,626.70 -1.05% 1,130.00 0.00%
 More Info 
WOCKHARDT 290.35 -0.45% 290.15 -0.55%
 More Info 

BSE prices: October 27, 2020  09:18:00 AM    NSE prices: October 27, 2020  9:19:59 AM

Indian Pharma Stocks Update

The NIFTY PHARMA Index is currently trading at 11,389.6 (up 0.5%). The index is up 10.5% over the last 30 days. And over the last 1 year, it has gained 21.2%.

Within the Indian Pharma sector, the top gainers are IPCA LABS (up 2.6%) and DIVIS LABORATORIES (up 2.0%). On the other hand, AARTI DRUGS (down 4.5%) and TORRENT PHARMA (down 1.0%) are among the top losers.

Meanwhile, the benchmark NIFTY 50 is at 11,789.0 (up 0.2%).


What else is happening in the markets today? Dig in...


Today's Market

SGX Nifty Up 58 Points, Factors Behind the Stock Market Crash, September Quarter Results, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed a sharp sell-off yesterday and ended their session deep in the red.

Related Views on News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About (Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Oct 27, 2020 09:18 AM

COMPARE COMPANY

MARKET STATS